HER2-LAMP-sCD40L

N/A

Report date: 2022/05/26 15:34:08

Base Information

Drug NameHER2-LAMP-sCD40L
Drug Alias NameHER2-LAMP-sCD40L
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulatorsCD40 ligand modulatorsImmunostimulants
TargetsReceptor protein-tyrosine kinase erbB-2CD40 ligand
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunomic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunomic Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A